← back to search

Ivor S. Douglas

The Medical Center of Aurora ·
Area of research
Epidemiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Sepsis Diagnosis and Treatment, Respiratory Support and Mechanisms, Hemodynamic Monitoring and Therapy, and Intensive Care Unit Cognitive Disorders.
h-index
52
citations
30,367
works
323
NIH funding
primary concept
Medicine
email

Recent publications

Post–Intensive Care Syndrome and Caregiver Burden
JAMA Network Open 2025cited by 15position: middledoi
Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis
JAMA 2024cited by 33position: middledoi
Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial
The Lancet Respiratory Medicine 2024cited by 18position: middledoi
Association Between Neuromuscular Blocking Agents and Outcomes of Emergency Tracheal Intubation: A Secondary Analysis of Randomized Trials
Annals of Emergency Medicine 2024cited by 3position: middledoi
Video versus Direct Laryngoscopy for Tracheal Intubation of Critically Ill Adults
New England Journal of Medicine 2023cited by 310position: middledoi
Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 Months
JAMA Network Open 2023cited by 60position: middledoi
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor–Biased Ligand in Adults With COVID-19
JAMA 2023cited by 50position: middledoi
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial
The Lancet Respiratory Medicine 2023cited by 19position: middledoi
Effective hemodynamic monitoring
Critical Care 2022cited by 148position: middledoi
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)
EClinicalMedicine 2022cited by 37position: middledoi
Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19
JAMA Network Open 2021cited by 83position: middledoi
Core Outcome Measures for Trials in People With Coronavirus Disease 2019: Respiratory Failure, Multiorgan Failure, Shortness of Breath, and Recovery
Critical Care Medicine 2021cited by 64position: middledoi
Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19
CHEST Journal 2021cited by 53position: middledoi
Fluid Response Evaluation in Sepsis Hypotension and Shock
CHEST Journal 2020cited by 264position: firstdoi
Antibiotic Stewardship in the Intensive Care Unit. An Official American Thoracic Society Workshop Report in Collaboration with the AACN, CHEST, CDC, and SCCM
Annals of the American Thoracic Society 2020cited by 92position: middledoi
One-Year Outcomes Following Tracheostomy for Acute Respiratory Failure*
Critical Care Medicine 2019cited by 54position: lastdoi
Hospital Mechanical Ventilation Volume and Patient Outcomes: Too Much of a Good Thing?
Critical Care Medicine 2019cited by 19position: lastdoi
Update in Critical Care and Acute Respiratory Distress Syndrome 2018
American Journal of Respiratory and Critical Care Medicine 2019cited by 7position: firstdoi
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness
New England Journal of Medicine 2018cited by 567position: middledoi
Liberal Versus Restrictive Intravenous Fluid Therapy for Early Septic Shock: Rationale for a Randomized Trial
Annals of Emergency Medicine 2018cited by 148position: middledoi
Evidence-based Utilization of Noninvasive Ventilation and Patient Outcomes
Annals of the American Thoracic Society 2017cited by 34position: middledoi
Proceedings of the 14th annual conference of INEBRIA
Addiction Science & Clinical Practice 2017cited by 8position: middledoi
Analysis of Total Human Urinary Glycosaminoglycan Disaccharides by Liquid Chromatography–Tandem Mass Spectrometry
Analytical Chemistry 2015cited by 99position: middledoi
Surviving Sepsis Campaign
Critical Care Medicine 2013cited by 9,717position: middledoi
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
Intensive Care Medicine 2013cited by 7,331position: middledoi
Drotrecogin Alfa (Activated) in Adults with Septic Shock
New England Journal of Medicine 2012cited by 1,277position: middledoi
The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis
Nature Medicine 2012cited by 834position: middledoi
Beyond single-marker analyses: mining whole genome scans for insights into treatment responses in severe sepsis
The Pharmacogenomics Journal 2012cited by 45position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Matthew C. Exline · National Heart Lung and Blood Institute3 papers (2018–2025)Mitchell M. Levy · Brown University3 papers (2013–2020)Jean‐Louis Vincent · Spanish Clinical Research Network3 papers (2013–2022)Mark D. Williams · The Ohio State University Wexner Medical Center3 papers (2012–2020)Allan J. Walkey · UMass Memorial Health Care3 papers (2017–2019)Anuj Mehta · Hospital Authority3 papers (2017–2019)Andrew Rhodes · Zoetis (United States)3 papers (2012–2013)Flávia Ribeiro Machado · Brazilian Research in Intensive Care Network2 papers (2013–2013)Douglas Curran‐Everett · University of Colorado Denver2 papers (2019–2019)Clifford S. Deutschman · Northwell Health2 papers (2013–2013)Richard Beale · King's College London2 papers (2013–2013)S. A. R. Webb · The University of Western Australia2 papers (2013–2013)Gordon D. Rubenfeld · Sunnybrook Health Science Centre2 papers (2013–2013) · 2 papers (2012–2012)Jonathan Sevransky · Emory University2 papers (2013–2013)Derek C. Angus · Syngenta (United Kingdom)2 papers (2013–2013)Tiffany M. Osborn · Washington University in St. Louis2 papers (2013–2013)Herwig Gerlach · New York University2 papers (2013–2013)Charles L. Sprung · Hebrew University of Jerusalem2 papers (2013–2013)Roman Jaeschke · McMaster University2 papers (2013–2013)